Literature DB >> 23645670

Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding.

Kazunori Mizuno1, Sergei Boudko, Jürgen Engel, Hans Peter Bächinger.   

Abstract

Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen. A slower folding of the collagen helix is a potential cause for over-modifications. However, little is known about the rate of folding of type III collagen in patients with EDS. To understand the molecular mechanism of the effect of mutations, a system was developed for bacterial production of homotrimeric model polypeptides. The C-terminal quarter, 252 residues, of the natural human type III collagen was attached to (GPP)7 with the type XIX collagen trimerization domain (NC2). The natural collagen domain forms a triple helical structure without 4-hydroxylation of proline at a low temperature. At 33 °C, the natural collagenous part is denatured, but the C-terminal (GPP)7-NC2 remains intact. Switching to a low temperature triggers the folding of the type III collagen domain in a zipper-like fashion that resembles the natural process. We used this system for the two known EDS mutations (Gly-to-Val) in the middle at Gly-910 and at the C terminus at Gly-1018. In addition, wild-type and Gly-to-Ala mutants were made. The mutations significantly slow down the overall rate of triple helix formation. The effect of the Gly-to-Val mutation is much more severe compared with Gly-to-Ala. This is the first report on the folding of collagen with EDS mutations, which demonstrates local delays in the triple helix propagation around the mutated residue.

Entities:  

Keywords:  Collagen; Connective Tissue; Ehlers-Danlos Syndrome; Glycine Mutations; Mutant; Prolyl Isomerase; Protein Folding; Type III Collagen

Mesh:

Substances:

Year:  2013        PMID: 23645670      PMCID: PMC3696688          DOI: 10.1074/jbc.M113.462002

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  The NC2 domain of type IX collagen determines the chain register of the triple helix.

Authors:  Sergei P Boudko; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2012-11-06       Impact factor: 5.157

2.  The tissue form of type VII collagen is an antiparallel dimer.

Authors:  N P Morris; D R Keene; R W Glanville; H Bentz; R E Burgeson
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

3.  A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease.

Authors:  S R Pinnell; S M Krane; J E Kenzora; M J Glimcher
Journal:  N Engl J Med       Date:  1972-05-11       Impact factor: 91.245

4.  Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization.

Authors:  H P Bächinger; P Bruckner; R Timpl; D J Prockop; J Engel
Journal:  Eur J Biochem       Date:  1980-05

5.  Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.

Authors:  U Schwarze; W I Schievink; E Petty; M R Jaff; D Babovic-Vuksanovic; K J Cherry; M Pepin; P H Byers
Journal:  Am J Hum Genet       Date:  2001-09-27       Impact factor: 11.025

6.  Nucleation and propagation of the collagen triple helix in single-chain and trimerized peptides: transition from third to first order kinetics.

Authors:  Sergei Boudko; Sabine Frank; Richard A Kammerer; Jörg Stetefeld; Therese Schulthess; Ruth Landwehr; Ariel Lustig; Hans Peter Bächinger; Jürgen Engel
Journal:  J Mol Biol       Date:  2002-03-29       Impact factor: 5.469

7.  Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase.

Authors:  Wei-Man Wang; Seungbok Lee; Barry M Steiglitz; Ian C Scott; Carter C Lebares; M Leah Allen; Mitchell C Brenner; Kazuhiko Takahara; Daniel S Greenspan
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

8.  Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene.

Authors:  Alain Colige; Lieve Nuytinck; Ingrid Hausser; Anthonie J van Essen; Marc Thiry; Christian Herens; Lesley C Adès; Fransiska Malfait; Anne De Paepe; Peter Franck; Gerhard Wolff; Jan C Oosterwijk; J H Sillevis Smitt; Charles M Lapière; Betty V Nusgens
Journal:  J Invest Dermatol       Date:  2004-10       Impact factor: 8.551

9.  Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.

Authors:  J Bonadio; P H Byers
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

10.  Type III collagen can be present on banded collagen fibrils regardless of fibril diameter.

Authors:  D R Keene; L Y Sakai; H P Bächinger; R E Burgeson
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

View more
  11 in total

1.  A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis.

Authors:  Yoshihiro Ishikawa; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

2.  The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.

Authors:  Michael Frank; Juliette Albuisson; Brigitte Ranque; Lisa Golmard; Jean-Michael Mazzella; Laurence Bal-Theoleyre; Anne-Laure Fauret; Tristan Mirault; Nicolas Denarié; Elie Mousseaux; Pierre Boutouyrie; Jean-Noël Fiessinger; Joseph Emmerich; Emmanuel Messas; Xavier Jeunemaitre
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

3.  A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.

Authors:  Sherene Shalhub; Peter H Byers; Kelli L Hicks; Kristofer Charlton-Ouw; Devin Zarkowsky; Dawn M Coleman; Frank M Davis; Ellen S Regalado; Giovanni De Caridi; K Nicole Weaver; Erin M Miller; Marc L Schermerhorn; Katie Shean; Gustavo Oderich; Mauricio Ribeiro; Cole Nishikawa; Christian-Alexander Behrendt; E Sebastian Debus; Yskert von Kodolitsch; Richard J Powell; Melanie Pepin; Dianna M Milewicz; Peter F Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-21       Impact factor: 4.268

4.  Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome.

Authors:  Caitlin J Bowen; Juan Francisco Calderón Giadrosic; Zachary Burger; Graham Rykiel; Elaine C Davis; Mark R Helmers; Kelly Benke; Elena Gallo MacFarlane; Harry C Dietz
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

5.  Ziploc-ing the structure 2.0: Endoplasmic reticulum-resident peptidyl prolyl isomerases show different activities toward hydroxyproline.

Authors:  Yoshihiro Ishikawa; Kazunori Mizuno; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2017-04-06       Impact factor: 5.157

6.  Open angle glaucoma in a case of Type IV Ehler Danlos syndrome: a rarely reported association.

Authors:  Arijit Mitra; R Ramakrishnan; Mohideen Abdul Kader
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

7.  Inherited Disease Genetics Improves the Identification of Cancer-Associated Genes.

Authors:  Boyang Zhao; Justin R Pritchard
Journal:  PLoS Genet       Date:  2016-06-15       Impact factor: 5.917

8.  Recurrent pneumothorax and intrapulmonary cavitary lesions in a male patient with vascular Ehlers-Danlos syndrome and a novel missense mutation in the COL3A1 gene: a case report.

Authors:  Tingting Wan; Jinyan Ye; Peiliang Wu; Mengshi Cheng; Baihong Jiang; Hailong Wang; Jianmin Li; Jun Ma; Liangxing Wang; Xiaoying Huang
Journal:  BMC Pulm Med       Date:  2020-05-29       Impact factor: 3.317

Review 9.  Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome.

Authors:  Ramla Omar; Fransiska Malfait; Tom Van Agtmael
Journal:  Matrix Biol Plus       Date:  2021-11-09

Review 10.  Animal Models of Ehlers-Danlos Syndromes: Phenotype, Pathogenesis, and Translational Potential.

Authors:  Robin Vroman; Anne-Marie Malfait; Rachel E Miller; Fransiska Malfait; Delfien Syx
Journal:  Front Genet       Date:  2021-10-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.